Search results for: 'global molecular diagnostic market opportunities ad growth indicators'

This research study presents an analysis of and growth opportunities for the global molecular imaging (MI) equipment market. It offers an in-depth analysis of the current trends, market size, revenue forecast (2022–2026), and market penetration of PET/CT, PET/MRI, SPECT, and SPECT/CT systems. Each year, more than 36 million MI procedures are per...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure vo...

With digital transformation and organizations transitioning to the cloud, network access control (NAC) solutions have moved from strengthening an organization’s internal infrastructure security to supporting unique policies on how and when endpoints connect to networks. NAC products and services offer visibility into and control over endpoints atte...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

The residential solar PV segment is witnessing a period of fast growth, driven by a combination of an increasingly favorable regulatory climate, higher electricity prices, and concerns over climate change. The restraints that have held the market back, primarily delays in approvals, have grown weaker, as governments gradually tackle these issues. T...

Developed European nations have had a challenging socioeconomic environment in 2022, especially amidst highly volatile geopolitical tensions and record-high inflationary pressures. Economic growth is likely to remain subdued in 2023 across the whole region as high energy costs weigh on household spending and lower profit margins of businesses, give...